These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1270179)

  • 21. AKR leukemogenesis: identification and biological significance of thymic lymphoma receptors for AKR retroviruses.
    McGrath MS; Weissman IL
    Cell; 1979 May; 17(1):65-75. PubMed ID: 222476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations.
    Fleischmann WR; Kleyn KM; Baron S
    J Natl Cancer Inst; 1980 Nov; 65(5):963-6. PubMed ID: 6159498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EARLY AND LATE LEUKEMIAS IN RATS AFTER TRANSPLANTATION OF LEUKEMIC CELLS FROM AKR MICE.
    KIRSTEN WH; PLATZ CE
    Cancer Res; 1964 Jul; 24():1056-62. PubMed ID: 14195343
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphomagenesis in AKR.Fv-1b congenic mice.
    Haran-Ghera N; Peled A; Brightman BK; Fan H
    Cancer Res; 1993 Jul; 53(14):3433-8. PubMed ID: 8324753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of the viral genome in interferon-treated cells infected with oncogneic or nononcogenic viruses.
    Friedman RM; Costa JC; Ramseur JM; Meyers MW; Jay FT; Chang EH
    J Infect Dis; 1976 Jun; 133 Suppl():A43-50. PubMed ID: 180209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma.
    Truitt RL; Rimm AA; Saltzstein EC; Rose WC; Bortin MM
    Transplant Proc; 1976 Dec; 8(4):569-74. PubMed ID: 11589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR mice.
    Rose WC; Rimm AA; Saltzstein EC; Truitt RL; Bortin MM
    J Natl Cancer Inst; 1975 Jul; 55(1):219-21. PubMed ID: 1159816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of oral administration of Pfaffia paniculata (Brazilian ginseng) on incidence of spontaneous leukemia in AKR/J mice.
    Watanabe T; Watanabe M; Watanabe Y; Hotta C
    Cancer Detect Prev; 2000; 24(2):173-8. PubMed ID: 10917139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.
    Hira SK; Mondal I; Bhattacharya D; Gupta KK; Manna PP
    Int J Biochem Cell Biol; 2015 Oct; 67():1-13. PubMed ID: 26255115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous and induced appearance of murine leukemia virus antigen containing cells in organ cultures of embryonic mouse thymus.
    Riesenfeld I; Alm GV
    Int J Cancer; 1977 Aug; 20(2):309-17. PubMed ID: 70415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of interferon on C1300 mouse neuroblastoma.
    Tozawa M; Kidowaki T; Tanaka T; Sawada T; Kusunoki T; Oku T; Kishida T
    Cancer Treat Rep; 1982 Jul; 66(7):1575-7. PubMed ID: 6178506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous leukemia viruses: lymphomagenic ecotropic viruses of AKR mice.
    Hays EF; Margaretten N; Swanson SK
    J Natl Cancer Inst; 1982 Nov; 69(5):1077-82. PubMed ID: 6290735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EFFECT OF 20-METHYLCHOLANTHRENE GIVEN AT BIRTH ON TUMOR DEVELOPMENT IN TWO HIGH-LEUKEMIA STRAINS OF MICE, AKR AND SL.
    NISHIZUKA Y; NAKAKUKI K
    Gan; 1964 Feb; 55():83-5. PubMed ID: 14134002
    [No Abstract]   [Full Text] [Related]  

  • 35. Applied and induced interferon in the prophylaxis and treatment of leukemia.
    Wheelock EF
    Arch Intern Med; 1970 Jul; 126(1):64-8. PubMed ID: 4316619
    [No Abstract]   [Full Text] [Related]  

  • 36. Transplacental interferon-mediated effect in AKR mice.
    Murasko DM; Blank KJ
    Virology; 1980 Oct; 106(1):148-51. PubMed ID: 6158164
    [No Abstract]   [Full Text] [Related]  

  • 37. Maternally transmitted resistance to lymphoma development in mice of reciprocal crosses of the RF/J and AKR/J strains.
    Mayer A; Struuck FD; Duran-Reynals ML; Lilly F
    Cell; 1980 Feb; 19(2):431-6. PubMed ID: 6244110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses.
    Cloyd MW; Hartley JW; Rowe WP
    J Exp Med; 1980 Mar; 151(3):542-52. PubMed ID: 6244357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fv-1 regulation of lymphoma development and of thymic ecotropic and xenotropic MuLV expression in mice of the AKR/J x RF/J cross.
    Mayer A; Duran-Reynals ML; Lilly F
    Cell; 1978 Oct; 15(2):429-35. PubMed ID: 214239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon: an anti-cancer agent?
    Priestman TJ
    Cancer Treat Rev; 1979 Dec; 6(4):223-37. PubMed ID: 394839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.